High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
723.73M
-1.49%
0.268
-64.29%
634.91M
-7.92%
0.105
-76.61%
630.36M
-4.23%
0.165
-45.08%
Estimates Revision
The market is revising Upward the revenue expectations for AMN Healthcare Services, Inc. (AMN) for FY2025, with the revenue forecasts being adjusted by 4.3% over the past three months. During the same period, the stock price has changed by -20.53%.
Revenue Estimates for FY2025
Revise Upward
+4.3%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+23.38%
In Past 3 Month
Stock Price
Go Down
-20.53%
In Past 3 Month
7 Analyst Rating
Wall Street analysts forecast AMN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMN is 22.17 USD with a low forecast of 20.50 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
3 Hold
1 Sell
Moderate Buy
Current: 16.570
Low
20.50
Averages
22.17
High
24.00
Current: 16.570
Low
20.50
Averages
22.17
High
24.00
UBS
Neutral
maintain
$18
2025-11-07
Reason
UBS
Price Target
$18
2025-11-07
maintain
Neutral
Reason
UBS raised the firm's price target on AMN Healthcare to $20.50 from $18 and keeps a Neutral rating on the shares.
Citizens JMP
Outperform
maintain
$22 -> $24
2025-11-07
Reason
Citizens JMP
Price Target
$22 -> $24
2025-11-07
maintain
Outperform
Reason
Citizens JMP raised the firm's price target on AMN Healthcare to $24 from $22 and keeps an Outperform rating on the shares. Management noted that travel nurse demand has steadily increased 50% from the mid-May lows, and remains slightly down year over year, while Allied demand is now flat y/y, the analyst tells investors in a research note. Although staffing gross margin has been under pressure, management believes this dynamic will stabilize as the industry returns to growth, with a rebound in the international nurse business serving as an additional margin tailwind, the firm says.
BofA
Underperform
downgrade
$20 -> $18
2025-09-10
Reason
BofA
Price Target
$20 -> $18
2025-09-10
downgrade
Underperform
Reason
BofA lowered the firm's price target on AMN Healthcare to $18 from $20 and keeps an Underperform rating on the shares. While hospital fundamentals should remain solid in the second half, the firm is concerned that the policy and reimbursement environment will be more negative compared to recent years, says the analyst, who prefers post-acute over hospitals as the least exposed to the upcoming cuts given this backdrop. The firm is updating estimates and price targets for several companies in its health care facilities coverage.
Citizens JMP
Constantine Davides
Outperform
downgrade
$33 -> $22
2025-08-12
Reason
Citizens JMP
Constantine Davides
Price Target
$33 -> $22
2025-08-12
downgrade
Outperform
Reason
Citizens JMP analyst Constantine Davides lowered the firm's price target on AMN Healthcare to $22 from $33 and keeps an Outperform rating on the shares. AMN's Q2 revenue exceeded the firm's estimates, and Citizens is encouraged by stable Q3 order and extension trends to-date following the impact from broader secular uncertainty in May and June, the analyst tells investors in a research note. While near-term staffing trends may remain choppy, the longer-term risk/reward profile of shares remains attractive, the firm says.
BMO Capital
Jeffrey Silber
Outperform
downgrade
$27 -> $22
2025-08-11
Reason
BMO Capital
Jeffrey Silber
Price Target
$27 -> $22
2025-08-11
downgrade
Outperform
Reason
BMO Capital analyst Jeffrey Silber lowered the firm's price target on AMN Healthcare to $22 from $27 and keeps an Outperform rating on the shares. The company again delivered a margin-driven beat to consensus, though while hospital commentary had been improving, the recent government policies and macro volatility softened volumes, the analyst tells investors in a research note.
UBS
Neutral
downgrade
$30
2025-05-13
Reason
UBS
Price Target
$30
2025-05-13
downgrade
Neutral
Reason
UBS lowered the firm's price target on AMN Healthcare to $25.50 from $30 and keeps a Neutral rating on the shares.
See All Ratings
Valuation Metrics
The current forward P/E ratio for AMN Healthcare Services Inc (AMN.N) is 21.37, compared to its 5-year average forward P/E of 16.24. For a more detailed relative valuation and DCF analysis to assess AMN Healthcare Services Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Overvalued
5Y Average PE
16.24
Current PE
21.37
Overvalued PE
20.97
Undervalued PE
11.51
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
9.03
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.72
Undervalued EV/EBITDA
7.34
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.89
Current PS
0.00
Overvalued PS
1.26
Undervalued PS
0.51
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AMN News & Events
Events Timeline
(ET)
2025-11-06
16:49:38
AMN Healthcare Projects Q4 Revenue Between $715M and $730M, Exceeding Consensus of $621.33M
2025-11-06
16:46:46
AMN Healthcare announces Q3 adjusted earnings per share of 39 cents, surpassing consensus estimate of 20 cents.
2025-09-22 (ET)
2025-09-22
08:25:56
AMN Healthcare introduces $400 million senior notes offering
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/148363d7c674cec46b209ef26c4ee4a41fc034d40455e8bdc674d5b1b9b4ef8a.jpg)
Preview
3.0
11-10NASDAQ.COMPRF's Holdings May Offer 14% Growth Opportunity
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/954c0435439d7bd13555715ca5cf156d5758f3837215e93536e86377f4c50fdf.jpg)
Preview
8.0
11-08NASDAQ.COMSignificant Friday Options Trading: AMN, DELL, EOSE
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/f2147126bcf72a16335cca9c2f1fe91a88e71aa94467fe257f231b4359a70d95.jpg)
Preview
9.5
11-07NASDAQ.COMAMN Healthcare Services (AMN) Surpasses Q3 Earnings and Revenue Projections
Sign Up For More News
People Also Watch
FAQ
What is AMN Healthcare Services Inc (AMN) stock price today?
What is AMN Healthcare Services Inc (AMN)'s business?
What is the price predicton of AMN Stock?
What is AMN Healthcare Services Inc (AMN)'s revenue for the last quarter?
What is AMN Healthcare Services Inc (AMN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for AMN Healthcare Services Inc (AMN)'s fundamentals?
How many employees does AMN Healthcare Services Inc (AMN). have?